Kesimpta (Ofatumumab): A B-Cell Depleting Injection for MS

By Dr. Emily Hanover and Hanover

Kesimpta (Ofatumumab): A B-Cell Depleting Injection for Multiple Sclerosis is a comprehensive guide to one of the most innovative treatments for relapsing forms of multiple sclerosis (MS). Written with both patients and healthcare professionals in mind, this book explores the science behind Kesimpta's targeted mechanism, its clinical efficacy, and its role in modern MS management.

Covering everything from pharmacokinetics and administration guidelines to real-world patient experiences and emerging research, this book provides a detailed look at how B-cell depletion is transforming MS treatment. Readers will gain a deeper understanding of the advantages of self-administered injections, the impact of B-cell targeting on disease progression, and the latest clinical trial insights.

Whether you are an MS patient seeking to make informed treatment decisions, a caregiver looking to understand new therapeutic options, or a medical professional interested in the evolving landscape of MS therapies, this book delivers the essential knowledge needed to navigate Kesimpta's benefits and considerations.

• Format: Paperback
• Language: English
• ISBN: B0DZXZ82L6
• ISBN13: 9798313578316
• Release Date: March 2025
• Publisher: Independently Published
• Length: 224 Pages
• Weight: 0.67 lbs.
• Dimensions: 0.5" x 6.0" x 9.0"